A Study Evaluating TRIV-573 in Atopic Dermatitis
Public ClinicalTrials.gov record NCT07782333. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Multicenter, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Multiple Subcutaneous Doses of TRIV-573 in Participants With Moderate to Severe Atopic Dermatitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The goal of this interventional study is to learn if TRIV-573 works to treat moderate to severe atopic dermatitis in adults. It will also evaluate the safety of TRIV-573. Participants will receive 5 doses of the study intervention that they are randomized to (TRIV-573 or placebo). The study duration for individual participants is up to 40 weeks, including a Screening period of up to 30 days.
Study identification
- NCT ID
- NCT07782333
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 90 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 9, 2026 (Actual)
- Primary completion
- Aug 2027 (Estimated)
- Completion
- Feb 2028 (Estimated)
- Last update posted
- Oct 28, 2026
2026 – 2028
United States locations
- U.S. sites
- 13
- U.S. states
- 9
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Triveni Bio Site #15 | Fountain Valley | California | 92708 | Recruiting |
| Triveni Bio Site #4 | Los Angeles | California | 90045 | Recruiting |
| Triveni Bio Site #11 | Boca Raton | Florida | 33486 | Recruiting |
| Triveni Bio Site #7 | Miami | Florida | 33126 | Recruiting |
| Triveni Bio Site #3 | Miami | Florida | 33142 | Recruiting |
| Triveni Bio Site #2 | Indianapolis | Indiana | 46250 | Recruiting |
| Triveni Bio Site #13 | Bay City | Michigan | 48706 | Recruiting |
| Triveni Bio Site #16 | Boardman | Ohio | 44512 | Recruiting |
| Triveni Bio Site #1 | Camp Hill | Pennsylvania | 17011 | Recruiting |
| Triveni Bio Site #14 | Myrtle Beach | South Carolina | 29588 | Recruiting |
| Triveni Bio Site #9 | San Antonio | Texas | 78213 | Recruiting |
| Triveni Bio Site #6 | San Antonio | Texas | 78218 | Recruiting |
| Triveni Bio Site #8 | Spokane | Washington | 99202 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07782333, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 28, 2026 · Synced Oct 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT07782333 live on ClinicalTrials.gov.